Post-Polio Syndrome
Also known as: Post-Poliomyélitis Syndrom / Postpoliomyelitis Syndrome / Post-Poliomyelitis Syndrome / Postpolio Syndrome / Post Polio Syndrome, PPS / Post polio syndrome / Post poliomyelitis syndrome (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00545 | Pyridostigmine | A cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00545 | Pyridostigmine | Acetylcholinesterase | target |
DB00545 | Pyridostigmine | Cholinesterase | target |
DB00545 | Pyridostigmine | Acetylcholinesterase | enzyme |
DB00545 | Pyridostigmine | Cholinesterase | enzyme |
DB00545 | Pyridostigmine | Cytochrome P450 3A4 | enzyme |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00028 | Human immunoglobulin G | 2 / 3 | Terminated | 1 |
DB00155 | Citrulline | 3 | Completed | 1 |
DB00028 | Human immunoglobulin G | 3 | Completed | 1 |
DB00583 | Levocarnitine | 3 | Withdrawn | 1 |
DB00745 | Modafinil | 3 | Terminated | 1 |
DB09210 | Piracetam | 3 | Withdrawn | 1 |